Next-generation sequencing for MRD monitoring in B-lineage malignancies: from bench to bedside

Minimal residual disease (MRD) is considered the strongest relevant predictor of prognosis and an effective decision-making factor during the treatment of hematological malignancies. Remarkable breakthroughs brought about by new strategies, such as epigenetic therapy and chimeric antigen receptor-T...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Xinyue, Zhang, Meilan, Zhou, Jianfeng, Xiao, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440501/
https://www.ncbi.nlm.nih.gov/pubmed/36057673
http://dx.doi.org/10.1186/s40164-022-00300-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440501/
https://www.ncbi.nlm.nih.gov/pubmed/36057673
http://dx.doi.org/10.1186/s40164-022-00300-2

Ejemplares similares